Editorial Board
Loris Rizzello
Department of Chemistry, University College London · United Kingdom
Editorial leadership for Journal of Biomaterials
Research interests
- Cell Culture
- Material Characterization
- Materials
- Nanomaterials
- Molecular Biology
- Polymers
- Nanomaterials Synthesis
- Cell Biology
- Microbiology
- Nanoparticle Synthesis
- Biomaterials
- Nanoparticles
- Materials Chemistry
- Nanotechnology
- Antimicrobials
- Microbial Molecular Biology
- Nanobiotechnology
- Nanoparticle Preparation
- Microscopy
- Bacteria
- Antibacterial Activity
- Antibacterials
- Molecular Biological Techniques
- Antimicrobial Susceptibility Testing
- Particle Size Analysis
- Functionalization
- Biofilm Formation
- Nanotechnology In Drug Delivery
- Nanomedicine
- Bionanotechnology
- Microbiology Techniques
- Nanotoxicology
- Medical Nanotechnology
- Nanotoxicity
- Nano Biomaterial
Biography
Grants, Awards, and Fellowships:
- 2017 EMBO short-term Fellowship, Project title: Molecular cell surface barcodes of infected macrophages. Visiting lab: Prof. Tambet Teesalu, The Laboratory of Cancer Biology, The University of Tartu - Estonia.
- 2015 - 2025 Newton Alumni, The Royal Society, London, UK , Value: £60,000 (£6,000/year), ready to be used for collaborations between UK and foreign Academic Institutions.
- 2014 - 2015 The Newton International Fellowship, The Royal Society, London, UK , Project title: Novel bio-nanomaterials for defeating tuberculosis. Principal Investigator, total value: £100,000. Success rate: 4%
- 2013 - 2014 The Lady Davis Fellowship Trust, The Hebrew University of Jerusalem , Project title: Revealing the molecular aspects of interactions between prokaryotes and colloidal nanomaterials. Refused for accepting another position.
- 2006 - 2008 ISUFI award (International Institution for the Interdisciplinary University Formation).
Considering JBI for your work?
This journal is guided by Loris Rizzello (Department of Chemistry, University College London) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.